These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 27656852)

  • 1. Epidemiological profile and prognostic factors in patients with lung cancer.
    Trufelli DC; Moraes TV; Lima AA; Giglio AD
    Rev Assoc Med Bras (1992); 2016; 62(5):428-33. PubMed ID: 27656852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in Brazil.
    Costa G; Thuler LC; Ferreira CG
    Lung Cancer; 2016 Jul; 97():66-72. PubMed ID: 27237030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
    Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004.
    Inoue M; Okumura M; Sawabata N; Miyaoka E; Asamura H; Yoshino I; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Kobayashi H; Yokoi K
    Lung Cancer; 2014 Feb; 83(2):246-51. PubMed ID: 24296124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in lung cancer: a 10-year study in a chest hospital.
    Malignancy Study Group of Izmir Training and Research Hospital for Thoracic Medicine and Surgery (ITRHTMS)
    Monaldi Arch Chest Dis; 2008 Dec; 69(4):157-63. PubMed ID: 19350837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison study of clinicoradiological profile of primary lung cancer cases: an Eastern India experience.
    Dey A; Biswas D; Saha SK; Kundu S; Kundu S; Sengupta A
    Indian J Cancer; 2012; 49(1):89-95. PubMed ID: 22842174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
    Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
    Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.
    Noonan K; Tong KM; Laskin J; Melosky B; Sun S; Murray N; Ho C
    Lung Cancer; 2014 Dec; 86(3):344-9. PubMed ID: 25439436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
    Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
    J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
    Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
    Baggstrom MQ; Waqar SN; Sezhiyan AK; Gilstrap E; Gao F; Morgensztern D; Govindan R
    J Thorac Oncol; 2011 Jan; 6(1):98-102. PubMed ID: 21150469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical statistical analysis of 4,931 lung cancer cases in Japan according to histological type--field study results. A report from the Japanese Joint Committee of Lung Cancer Associated with the TNM System of Clinical Classification (UICC).
    Yoshimura K
    Radiat Med; 1984; 2(4):237-51. PubMed ID: 6100397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the therapeutic measures in lung cancer].
    Berëzkin DP; Vagner RI; Ekimov VI; Filatov VN
    Vopr Onkol; 1988; 34(8):936-42. PubMed ID: 2458655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and survival from lung cancer in Greenland is comparable to survival in the Nordic countries.
    Gelvan A; Risum S; Langer SW
    Dan Med J; 2015 Apr; 62(4):A5033. PubMed ID: 25872548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience.
    Noronha V; Dikshit R; Raut N; Joshi A; Pramesh CS; George K; Agarwal JP; Munshi A; Prabhash K
    Indian J Cancer; 2012; 49(1):74-81. PubMed ID: 22842172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
    Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
    Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.